↓ Skip to main content

The risk-value trade-off: price and brand information impact consumers’ intentions to purchase OTC drugs

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, January 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 X users

Readers on

mendeley
92 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The risk-value trade-off: price and brand information impact consumers’ intentions to purchase OTC drugs
Published in
Journal of Pharmaceutical Policy and Practice, January 2021
DOI 10.1186/s40545-020-00293-5
Pubmed ID
Authors

Lisa Aufegger, Celine Yanar, Ara Darzi, Colin Bicknell

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 92 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 92 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 7 8%
Researcher 6 7%
Lecturer 6 7%
Student > Master 4 4%
Student > Ph. D. Student 3 3%
Other 9 10%
Unknown 57 62%
Readers by discipline Count As %
Business, Management and Accounting 18 20%
Economics, Econometrics and Finance 4 4%
Unspecified 2 2%
Pharmacology, Toxicology and Pharmaceutical Science 2 2%
Environmental Science 2 2%
Other 6 7%
Unknown 58 63%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 February 2021.
All research outputs
#13,731,468
of 23,275,636 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#241
of 421 outputs
Outputs of similar age
#244,295
of 505,027 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#17
of 27 outputs
Altmetric has tracked 23,275,636 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 421 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.0. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 505,027 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.